article Open AccessTop 1% cited

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Annals of Oncology · 2015 · Vol. 26(8) · pp. 1533–1546

Alan S. Coates(Breast Cancer Trials)Eric P. Winer(Harvard University)Aron Goldhirsch(European Institute of Oncology)Richard D. Gelber(Dana-Farber Cancer Institute)Michael Gnant(Medical University of Vienna)Martine Piccart(Institut Jules Bordet)Beat Thürlimann(Breast Center)H.-J. Senn(Breast Center)Fabrice AndréJosé BaselgaJonas BerghHervé BonnefoiHarold J. BursteinFátima CardosoMonica Castiglione‐GertschAlan S. Coates(University of Sydney)Marco ColleoniGiuseppe CuriglianoNancy E. DavidsonAngelo Di LeoBent EjlertsenJohn ForbesViviana GalimbertiRichard D. Gelber(Dana-Farber Cancer Institute)Michael Gnant(Medical University of Vienna)Aron Goldhirsch✉(European Institute of Oncology)Pamela J. GoodwinNadia HarbeckDaniel F. HayesJens HuoberClifford A. HudisJames N. IngleJacek JassemZefei JiangPer KarlssonMonica MorrowRoberto OrecchiaC. Kent OsborneAnn H. PartridgeLorena de la PeñaMartine Piccart(Institut Jules Bordet)Kathleen I. PritchardEmiel J. RutgersFelix SedlmayerSemiglazov VfZhi‐Ming ShaoIan SmithBeat Thürlimann(Kantonsspital St. Gallen)Masakazu ToiAndrew TuttGiuseppe VialeGϋnter von MinckwitzToru WatanabeTimothy J. WhelanEric P. Winer(Harvard University)Binghe Xu

View via DOI Full-text PDF

Breast Cancer Treatment Studies Advanced Breast Cancer Therapies HER2/EGFR in Cancer ResearchMedicineBreast cancerTrastuzumabOncologyInternal medicineTamoxifenExemestaneRadiation therapyTargeted therapyCancer

MeSH terms

TrastuzumabAntineoplastic Combined Chemotherapy ProtocolsAxillaBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingFemaleHumansLymph Node ExcisionMastectomyNeoplasm StagingReceptors, EstrogenReceptors, ProgesteroneTamoxifenMastectomy, SegmentalChemotherapy, Adjuvant